Our board of directors is currently composed of five members. Each director currently serves until the next annual meeting of stockholders or until his successor is duly elected and qualified. At each annual meeting of stockholders, the directors' successors will be elected to serve until the next annual meeting of stockholders.
Our board of directors held one meeting during 2006. Each of the then current directors attended or participated in 75% or more of the aggregate of (i) the total number of meetings of our board of directors and (ii) the total number of meetings held by all committees of our board on which such director served during 2006.
Although we do not have a policy with regard to attendance by members of our board of directors at our annual meeting of stockholders, it is customary for all members of our board of directors to attend. All of our directors were present for our 2007 annual meeting.
Chemokine's current Board of Directors is comprised of the following members:
Ph.D. Chairman & Chief Scientific Officer View Bio
CPA, Director Mr. Kuhn has been a director since December 2007. He is an experienced businessman with over 20 years in trading securities actively through his fund, Lakeside Investments. For the past 15 years Mr. Kuhn has also provided consulting and review of public offerings for Broidy Capital (a private equity fund based out of Los Angeles, CA). Mr. Kuhn obtained his CPA from the California State Board of Accountancy in 1990. He spent four years at Arthur Andersen & Co. before leaving to start his own firm. He has extensive accounting experience and has participated in a number of public as well as private security investments. Mr. Kuhn is involved in several start-up businesses and charity organizations in Southern California.
BA Director Mr. Byrd has been a director since December 2007. He is an entrepreneur with more than 20 years experience in a variety of business ventures. Currently Mr. Byrd is the President and CEO of Secure EDI, a healthcare IT company that operates in the US and in Puerto Rico as Inmediata. Previously, Mr. Byrd served as Chairman of HRAmerica, a company which he founded and served as its Chairman and CEO until April 2005. He was President of Human Resource ONE, a company that he founded, sold and brought public as NovaCare Employee Services in 1997. In the past Mr. Byrd also served as VP of Finance for Your Staff, Inc and CFO of Staffing Services, Inc. Mr. Byrd graduated from California State Polytechnic University and holds a degree in Business Administration. Mr. Byrd also serves on the Board of Trustees for Speedway Children's Charities.
Director Mr. Kowalchuk has been a director since December 2007. He is a retired businessman and investor with thirty years of investment experience related to biotechnology companies.
Mr. Bahadori has been a directoir since December 2007. He is a Senior Financial Advisor at Paulson Investment Company. Mr. Bahadori has been involved in a number of transactions for various healthcare and technology companies. He is an active member of RIBA (Regional Investment Bankers Association) and is a Registered Investment Advisor with FINRA (formally NASD). He has extensive knowledge of financial and investment banking.
